Hospital Acquired Infection Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 105 pages | ID: HB4D4B3DF640EN
Market Monitor Global

Abstracts

Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility.

This report contains market size and forecasts of Hospital Acquired Infection Treatment in Global, including the following market information:

Global Hospital Acquired Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hospital Acquired Infection Treatment market was valued at 19390 million in 2021 and is projected to reach US$ 21570 million by 2028, at a CAGR of 1.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Urinary Tract Infections Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hospital Acquired Infection Treatment include Abbott, Pfizer, Bayer, Cepheid, AstraZeneca, Roche, Johnson & Johnson, Merck and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital Acquired Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hospital Acquired Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hospital Acquired Infection Treatment Market Segment Percentages, by Type, 2021 (%)

• Urinary Tract Infections
• Ventilator Associated Pneumonia
• Surgical Site Infections
• Bloodstream Infections
• Gastrointestinal Infection
• ENT Infections
• Skin Infection
• Bone Infection

Global Hospital Acquired Infection Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hospital Acquired Infection Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Drug Store
• E-Commerce

Global Hospital Acquired Infection Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hospital Acquired Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hospital Acquired Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hospital Acquired Infection Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Pfizer
• Bayer
• Cepheid
• AstraZeneca
• Roche
• Johnson & Johnson
• Merck
• Cipla
• GlaxoSmithKline
• Aridis Pharmaceuticals
• Astellas Pharma
• Daiichi Sankyo
• Bristol-Myers Squibb
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hospital Acquired Infection Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hospital Acquired Infection Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HOSPITAL ACQUIRED INFECTION TREATMENT OVERALL MARKET SIZE

2.1 Global Hospital Acquired Infection Treatment Market Size: 2021 VS 2028
2.2 Global Hospital Acquired Infection Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hospital Acquired Infection Treatment Players in Global Market
3.2 Top Global Hospital Acquired Infection Treatment Companies Ranked by Revenue
3.3 Global Hospital Acquired Infection Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hospital Acquired Infection Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hospital Acquired Infection Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Acquired Infection Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Hospital Acquired Infection Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hospital Acquired Infection Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hospital Acquired Infection Treatment Market Size Markets, 2021 & 2028
  4.1.2 Urinary Tract Infections
  4.1.3 Ventilator Associated Pneumonia
  4.1.4 Surgical Site Infections
  4.1.5 Bloodstream Infections
  4.1.6 Gastrointestinal Infection
  4.1.7 ENT Infections
  4.1.8 Skin Infection
  4.1.9 Bone Infection
4.2 By Type - Global Hospital Acquired Infection Treatment Revenue & Forecasts
  4.2.1 By Type - Global Hospital Acquired Infection Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Hospital Acquired Infection Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hospital Acquired Infection Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Drug Store
  5.1.5 E-Commerce
5.2 By Application - Global Hospital Acquired Infection Treatment Revenue & Forecasts
  5.2.1 By Application - Global Hospital Acquired Infection Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Hospital Acquired Infection Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hospital Acquired Infection Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hospital Acquired Infection Treatment Revenue & Forecasts
  6.2.1 By Region - Global Hospital Acquired Infection Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Hospital Acquired Infection Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hospital Acquired Infection Treatment Revenue, 2017-2028
  6.3.2 US Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.3.3 Canada Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.3.4 Mexico Hospital Acquired Infection Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hospital Acquired Infection Treatment Revenue, 2017-2028
  6.4.2 Germany Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.4.3 France Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.4.4 U.K. Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.4.5 Italy Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.4.6 Russia Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.4.8 Benelux Hospital Acquired Infection Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hospital Acquired Infection Treatment Revenue, 2017-2028
  6.5.2 China Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.5.3 Japan Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.5.4 South Korea Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.5.6 India Hospital Acquired Infection Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hospital Acquired Infection Treatment Revenue, 2017-2028
  6.6.2 Brazil Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.6.3 Argentina Hospital Acquired Infection Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hospital Acquired Infection Treatment Revenue, 2017-2028
  6.7.2 Turkey Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.7.3 Israel Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Hospital Acquired Infection Treatment Market Size, 2017-2028
  6.7.5 UAE Hospital Acquired Infection Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Hospital Acquired Infection Treatment Major Product Offerings
  7.1.4 Abbott Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Hospital Acquired Infection Treatment Major Product Offerings
  7.2.4 Pfizer Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Hospital Acquired Infection Treatment Major Product Offerings
  7.3.4 Bayer Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bayer Key News
7.4 Cepheid
  7.4.1 Cepheid Corporate Summary
  7.4.2 Cepheid Business Overview
  7.4.3 Cepheid Hospital Acquired Infection Treatment Major Product Offerings
  7.4.4 Cepheid Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.4.5 Cepheid Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca Hospital Acquired Infection Treatment Major Product Offerings
  7.5.4 AstraZeneca Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.5.5 AstraZeneca Key News
7.6 Roche
  7.6.1 Roche Corporate Summary
  7.6.2 Roche Business Overview
  7.6.3 Roche Hospital Acquired Infection Treatment Major Product Offerings
  7.6.4 Roche Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.6.5 Roche Key News
7.7 Johnson & Johnson
  7.7.1 Johnson & Johnson Corporate Summary
  7.7.2 Johnson & Johnson Business Overview
  7.7.3 Johnson & Johnson Hospital Acquired Infection Treatment Major Product Offerings
  7.7.4 Johnson & Johnson Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.7.5 Johnson & Johnson Key News
7.8 Merck
  7.8.1 Merck Corporate Summary
  7.8.2 Merck Business Overview
  7.8.3 Merck Hospital Acquired Infection Treatment Major Product Offerings
  7.8.4 Merck Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.8.5 Merck Key News
7.9 Cipla
  7.9.1 Cipla Corporate Summary
  7.9.2 Cipla Business Overview
  7.9.3 Cipla Hospital Acquired Infection Treatment Major Product Offerings
  7.9.4 Cipla Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.9.5 Cipla Key News
7.10 GlaxoSmithKline
  7.10.1 GlaxoSmithKline Corporate Summary
  7.10.2 GlaxoSmithKline Business Overview
  7.10.3 GlaxoSmithKline Hospital Acquired Infection Treatment Major Product Offerings
  7.10.4 GlaxoSmithKline Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.10.5 GlaxoSmithKline Key News
7.11 Aridis Pharmaceuticals
  7.11.1 Aridis Pharmaceuticals Corporate Summary
  7.11.2 Aridis Pharmaceuticals Business Overview
  7.11.3 Aridis Pharmaceuticals Hospital Acquired Infection Treatment Major Product Offerings
  7.11.4 Aridis Pharmaceuticals Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.11.5 Aridis Pharmaceuticals Key News
7.12 Astellas Pharma
  7.12.1 Astellas Pharma Corporate Summary
  7.12.2 Astellas Pharma Business Overview
  7.12.3 Astellas Pharma Hospital Acquired Infection Treatment Major Product Offerings
  7.12.4 Astellas Pharma Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.12.5 Astellas Pharma Key News
7.13 Daiichi Sankyo
  7.13.1 Daiichi Sankyo Corporate Summary
  7.13.2 Daiichi Sankyo Business Overview
  7.13.3 Daiichi Sankyo Hospital Acquired Infection Treatment Major Product Offerings
  7.13.4 Daiichi Sankyo Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.13.5 Daiichi Sankyo Key News
7.14 Bristol-Myers Squibb
  7.14.1 Bristol-Myers Squibb Corporate Summary
  7.14.2 Bristol-Myers Squibb Business Overview
  7.14.3 Bristol-Myers Squibb Hospital Acquired Infection Treatment Major Product Offerings
  7.14.4 Bristol-Myers Squibb Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.14.5 Bristol-Myers Squibb Key News
7.15 Eli Lilly
  7.15.1 Eli Lilly Corporate Summary
  7.15.2 Eli Lilly Business Overview
  7.15.3 Eli Lilly Hospital Acquired Infection Treatment Major Product Offerings
  7.15.4 Eli Lilly Hospital Acquired Infection Treatment Revenue in Global Market (2017-2022)
  7.15.5 Eli Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hospital Acquired Infection Treatment Market Opportunities & Trends in Global Market
Table 2. Hospital Acquired Infection Treatment Market Drivers in Global Market
Table 3. Hospital Acquired Infection Treatment Market Restraints in Global Market
Table 4. Key Players of Hospital Acquired Infection Treatment in Global Market
Table 5. Top Hospital Acquired Infection Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hospital Acquired Infection Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hospital Acquired Infection Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hospital Acquired Infection Treatment Product Type
Table 9. List of Global Tier 1 Hospital Acquired Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Acquired Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hospital Acquired Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hospital Acquired Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hospital Acquired Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hospital Acquired Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hospital Acquired Infection Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hospital Acquired Infection Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Hospital Acquired Infection Treatment Product Offerings
Table 32. Abbott Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Hospital Acquired Infection Treatment Product Offerings
Table 35. Pfizer Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Hospital Acquired Infection Treatment Product Offerings
Table 38. Bayer Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Cepheid Corporate Summary
Table 40. Cepheid Hospital Acquired Infection Treatment Product Offerings
Table 41. Cepheid Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Hospital Acquired Infection Treatment Product Offerings
Table 44. AstraZeneca Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Roche Corporate Summary
Table 46. Roche Hospital Acquired Infection Treatment Product Offerings
Table 47. Roche Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Hospital Acquired Infection Treatment Product Offerings
Table 50. Johnson & Johnson Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Merck Corporate Summary
Table 52. Merck Hospital Acquired Infection Treatment Product Offerings
Table 53. Merck Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Cipla Corporate Summary
Table 55. Cipla Hospital Acquired Infection Treatment Product Offerings
Table 56. Cipla Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmithKline Corporate Summary
Table 58. GlaxoSmithKline Hospital Acquired Infection Treatment Product Offerings
Table 59. GlaxoSmithKline Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Aridis Pharmaceuticals Corporate Summary
Table 61. Aridis Pharmaceuticals Hospital Acquired Infection Treatment Product Offerings
Table 62. Aridis Pharmaceuticals Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Astellas Pharma Corporate Summary
Table 64. Astellas Pharma Hospital Acquired Infection Treatment Product Offerings
Table 65. Astellas Pharma Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Daiichi Sankyo Corporate Summary
Table 67. Daiichi Sankyo Hospital Acquired Infection Treatment Product Offerings
Table 68. Daiichi Sankyo Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Bristol-Myers Squibb Corporate Summary
Table 70. Bristol-Myers Squibb Hospital Acquired Infection Treatment Product Offerings
Table 71. Bristol-Myers Squibb Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Eli Lilly Corporate Summary
Table 73. Eli Lilly Hospital Acquired Infection Treatment Product Offerings
Table 74. Eli Lilly Hospital Acquired Infection Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hospital Acquired Infection Treatment Segment by Type in 2021
Figure 2. Hospital Acquired Infection Treatment Segment by Application in 2021
Figure 3. Global Hospital Acquired Infection Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hospital Acquired Infection Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hospital Acquired Infection Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital Acquired Infection Treatment Revenue in 2021
Figure 8. By Type - Global Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028
Figure 12. US Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028
Figure 24. China Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hospital Acquired Infection Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hospital Acquired Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cepheid Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Roche Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cipla Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmithKline Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Aridis Pharmaceuticals Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Astellas Pharma Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Daiichi Sankyo Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Bristol-Myers Squibb Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Eli Lilly Hospital Acquired Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)